TFPT Polyklonaler Antikörper

TFPT Polyklonal Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 10097-2-PBS

Synonyme

TCF3 fusion partner, Protein FB1, INO80F, INO80 complex subunit F, FB1

---

• 

  WB analysis of K-562 using 10097-2-AP (same clone as 10097-2-PBS)

  K-562 cells were subjected to SDS PAGE followed by western blot with 10097-2-AP (TFPT antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

• 

  WB analysis of HL-60 using 10097-2-AP (same clone as 10097-2-PBS)

  HL-60 cells were subjected to SDS PAGE followed by western blot with 10097-2-AP (TFPT antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

• 

  WB analysis of mouse liver using 10097-2-AP (same clone as 10097-2-PBS)

  mouse liver tissue were subjected to SDS PAGE followed by western blot with 10097-2-AP (TFPT Antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

• 

  WB analysis of PC-3 using 10097-2-AP (same clone as 10097-2-PBS)

  PC-3 cells were subjected to SDS PAGE followed by western blot with 10097-2-AP (TFPT antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

• 

  IHC staining of mouse liver using 10097-2-AP (same clone as 10097-2-PBS)

  Immunohistochemical analysis of paraffin-embedded mouse liver tissue slide using 10097-2-AP (TFPT antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

• 

  IHC staining of human brain using 10097-2-AP (same clone as 10097-2-PBS)

  Immunohistochemical analysis of paraffin-embedded human brain slide using 10097-2-AP (TFPT Antibody) at dilution of 1:50. This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

• 

  IHC staining of human brain using 10097-2-AP (same clone as 10097-2-PBS)

  Immunohistochemical analysis of paraffin-embedded human brain slide using 10097-2-AP (TFPT Antibody) at dilution of 1:50. This data was developed using the same antibody clone with 10097-2-PBS in a different storage buffer formulation.

---

Geprüfte Anwendungen

Produktinformation

10097-2-PBS bindet in WB, IHC, Indirect ELISA TFPT und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: TFPT fusion protein Ag0131
• Vollständiger Name: TCF3 (E2A) fusion partner (in childhood Leukemia)
• Berechnetes Molekulargewicht: 29 kDa
• Beobachtetes Molekulargewicht: 29 kDa
• GenBank-Zugangsnummer: BC001728
• Gene symbol: TFPT
• Gene ID (NCBI): 29844
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS only
• Lagerungsbedingungen: Store at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TFPT/FB1 is one of three fusion partners of the E2A gene. TFPT/FB1 is expressed at low level in a variety of human tissues, including hemopoietic cell lines from different lineages. The function of the putative TFPT/FB1 protein, however, is currently unknown as database sequence comparisons have failed to reveal strong homology with known proteins. The E2A-TFPT/FB1 fusion appears to be a recurrent feature of pre-B ALLs, suggesting that it might have a role in the development and/or progression of leukemogenesis. The gene encoding TFPT/FB1 is localized on 19q13.4.

{{ptg:RelatedPrimaryAntibodies}}